Literature DB >> 3381964

Compliance with fecal occult blood testing: the role of restrictive diets.

A Joseph1.   

Abstract

In this clinical trial, 786 patients screened for colorectal cancer with fecal occult blood testing were assigned to either a "diet" or "no diet" group to examine the effect of advice to restrict intake of red meat and peroxidase-containing vegetables on patient compliance and positivity rates. Restrictive diets did not significantly decrease compliance. Interviews of patients in the "diet" group demonstrated that the majority followed instructions. Positivity rates were similar in the two groups, and clinically significant lesions were found with comparable frequency.

Entities:  

Mesh:

Year:  1988        PMID: 3381964      PMCID: PMC1350349          DOI: 10.2105/ajph.78.7.839

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  16 in total

1.  What do we gain from the sixth stool guaiac?

Authors:  D Neuhauser; A M Lewicki
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

2.  Hemoccult stool tests: false-negative results due to storage of specimens.

Authors:  J R Stroehlein; V F Fairbanks; V L Go; W F Taylor; J H Thompson
Journal:  Mayo Clin Proc       Date:  1976-09       Impact factor: 7.616

3.  Optimal dietary conditions for hemoccult testing.

Authors:  F A Macrae; D J St John; P Caligiore; L S Taylor; J W Legge
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

4.  Peroxidase levels in food: relevance to colorectal cancer screening.

Authors:  P Caligiore; F A Macrae; D J St John; L J Rayner; J W Legge
Journal:  Am J Clin Nutr       Date:  1982-06       Impact factor: 7.045

5.  Detection of silent colon cancer in routine examination.

Authors:  D H Greegor
Journal:  CA Cancer J Clin       Date:  1969 Nov-Dec       Impact factor: 508.702

6.  Maximizing compliance with hemoccult screening for colon cancer in clinical practice.

Authors:  R S Thompson; M E Michnich; J Gray; L Friedlander; B Gilson
Journal:  Med Care       Date:  1986-10       Impact factor: 2.983

7.  The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study.

Authors:  V A Gilbertsen; R McHugh; L Schuman; S E Williams
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

8.  Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.

Authors:  F A Macrae; D J St John
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

9.  Comparative educational approaches to screening for colorectal cancer.

Authors:  T W Elwood; A Erickson; S Lieberman
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

10.  Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.

Authors:  S J Winawer; M Andrews; B Flehinger; P Sherlock; D Schottenfeld; D G Miller
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

View more
  3 in total

Review 1.  Dietary interventions for fecal occult blood test screening: systematic review of the literature.

Authors:  Gerald Konrad
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

2.  Implementation intentions and colorectal screening: a randomized trial in safety-net clinics.

Authors:  K Allen Greiner; Christine M Daley; Aaron Epp; Aimee James; Hung-Wen Yeh; Mugur Geana; Wendi Born; Kimberly K Engelman; Jeremy Shellhorn; Christina M Hester; Joseph LeMaster; Daniel C Buckles; Edward F Ellerbeck
Journal:  Am J Prev Med       Date:  2014-11-18       Impact factor: 5.043

3.  Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012.

Authors:  Diana Redwood; Ellen Provost; Elvin Asay; Diana Roberts; Donald Haverkamp; David Perdue; Michael G Bruce; Frank Sacco; David Espey
Journal:  Prev Chronic Dis       Date:  2014-04-10       Impact factor: 2.830

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.